The U.S. adds 12 Chinese entities to its export blacklist; Rules regulating listed companies to be consolidated; Didi ordered by regulators to delist from NYSE

Data processors may not take biometric features as the sole method of authenticating individuals' identities

Beijing Municipality issues rules to prohibit misappropriation of housing purchase funds

New rules are set forth for foreign-related certification. More details are required for working papers of securities offering sponsorship. Domestic bond credit rating is relied on more for insurance capital investment.

Compliance advice that recognizes business necessities is crucial for effective in-house work

Hong Kong finalizes secondary listing reforms to attract more Greater China Issuers; SAMR fines tech giants for failing to declare transactions; and German insurer Allianz approved to take full control of life insurance business

In China's first-ever securities class action, Kangmei Pharmaceuticals has been ordered to pay $385 million as compensation—just enough for 50,000 investors to recoup their losses.

Data processors may not take biometric features as the sole method of authenticating individuals' identities. Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector. Insurance capital may invest in REITs.

Apps are required to inform users of third party use of their personal information